or
forgot password

    • cancer clinical trials in myrtle beach, SC

    • Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
    Coastal Cancer Center - Myrtle Beach
    Myrtle Beach, South Carolina 29572
    Breast Cancer, Psychosocial Effects of Cancer and Its Treatment
    Denileukin Diftitox in Treating Patients With Non-Hodgkin's Lymphoma
    Coastal Cancer Center
    Myrtle Beach, South Carolina 29572
    Leukemia, Lymphoma
    R-Flurbiprofen in Treating Patients With Localized Prostate Cancer at Risk of Recurrence
    Grand Strand Urology LLP
    Myrtle Beach, South Carolina 29572
    Prostate Cancer
    Combination Chemotherapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer
    Coastal Cancer Center - Myrtle Beach
    Myrtle Beach, South Carolina 29572
    Lung Cancer
    Microsatellite Analysis of Urinary Sediment in Detecting Bladder Cancer
    Grand Strand Urology, LLP
    Myrtle Beach, South Carolina 29572
    Bladder Cancer
    Radiation Therapy in Treating Patients With Stage II Prostate Cancer
    Carolina Regional Cancer Center
    Myrtle Beach, South Carolina 29577
    Prostate Cancer
    Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy
    Associated Medical Specialists PA dba Coastal Cancer Center
    Myrtle Beach, South Carolina 29572
    Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Clinical Study of the Sonablate® 500 to Treat Localized (T1c/T2a) Prostate Cancer
    Brachytherapy Site: Grand Strand Urology
    Myrtle Beach, South Carolina 29572
    Prostate Cancer
    Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer
    Associated Medical Specialists PA dba Coastal Cancer Center
    Myrtle Beach, South Carolina 29572
    Male Breast Cancer, Recurrent Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    A Randomized Trial of Ixempra Versus Taxol in Adjuvant Therapy of Triple Negative Breast Cancer
    Coastal Cancer Center
    Myrtle Beach, South Carolina 29572
    Breast Cancer
    Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
    Carolina Urologic Research Center
    Myrtle Beach, South Carolina 29572
    Prostate Cancer
    Safety, Pharmacokinetic and Proof-of-Concept Study of ARN-509 in Castration-Resistant Prostate Cancer (CRPC)
    Carolina Urologic Research Center
    Myrtle Beach, South Carolina 29572
    Prostate Cancer
    Comparison of Docetaxel/Prednisone to Docetaxel/Prednisone in Combination With OGX-011 in Men With Prostate Cancer
    Teva Investigational Site 102
    Myrtle Beach, South Carolina
    Prostate Cancer
    A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
    Carolina Urologic Research Center
    Myrtle Beach, South Carolina 29572
    Prostatic Neoplasms
    A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
    Carolina Urologic Research Center
    Myrtle Beach, South Carolina 29572
    Advanced Prostate Cancer, Prostatic Neoplasms
    Cabazitaxel Versus Docetaxel Both With Prednisone in Patients With Metastatic Castration Resistant Prostate Cancer
    Investigational Site Number 840037
    Myrtle Beach, South Carolina 29572
    Prostate Cancer
    Safety and Pharmacokinetics Study of ODM-201 in Castrate Resistant Prostate Cancer
    Carolina Urologic Research Center
    Myrtle Beach, South Carolina 29572
    Prostate Cancer
    Phase III Study of the Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer (NSCLC)
    GTx Investigative Site
    Myrtle Beach, South Carolina 29572
    Muscle Wasting, Non Small Cell Lung Cancer
    Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer (NSCLC) on First Line Platinum
    GTx Investigative Site
    Myrtle Beach, South Carolina 29572
    Muscle Wasting, Non-Small Cell Lung Cancer
    Efficacy and Safety of Multi-Instillations of Apaziquone in Patients With Non-Muscle Invasive Bladder Cancer
    Carolina Urologic Research Center
    Myrtle Beach, South Carolina 29572
    Bladder Cancer
    Efficacy and Safety of Leuprolide Acetate 22.5 mg Depot in Treatment of Prostate Cancer
    Carolina Urologic Research Center
    Myrtle Beach, South Carolina 29572
    Prostate Cancer
    Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer
    Grand Strand Urology
    Myrtle Beach, South Carolina 29572
    Prostatic Neoplasm, Prostate Cancer, Prostatic Adenocarcinoma
    Concurrent Versus Sequential Treatment With Sipuleucel-T and Abiraterone in Men With Metastatic Castrate Resistant Prostate Cancer (mCRPC)
    Carolina Urologic Research Center
    Myrtle Beach, South Carolina 29572
    Prostate Cancer Metastatic, Hormone Refractory Prostate Cancer
    SpaceOAR System Pivotal Study
    21st Century Oncology
    Myrtle Beach, South Carolina 29577
    Prostate Cancer
    Phase 3 Trial of Autologous Dendritic Cell Immunotherapy (AGS-003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (RCC)
    Carolina Urologic Research Center
    Myrtle Beach, South Carolina 29572
    Advanced Renal Cell Carcinoma, Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma
    Provide Expanded Access to MDV3100 and Monitor Its Safety in Patients With Progressive Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy
    Carolina Urologic Research Center
    Myrtle Beach, South Carolina 29572
    Metastatic Castration-Resistant Prostate Cancer
    Two-Dose Level Evaluation of NX-1207 for the Treatment of Low Risk, Localized (T1c) Prostate Cancer
    For information concerning this clinical site, please contact Nymox at 800-936-9669.
    Myrtle Beach, South Carolina 29572
    Prostate Cancer
    Intravesical Administration of INSTILADRIN (rAd-IFN With Syn3) in Patients With Bladder Cancer
    Carolina Urologic Research Center
    Myrtle Beach, South Carolina 29572
    Superficial Bladder Cancer
    Immune Monitoring Protocol in Men With Prostate Cancer Enrolled in a Clinical Trial of Sipuleucel-T
    Carolina Urologic Research Center
    Myrtle Beach, South Carolina 29572
    Prostate Cancer
    Study With TMX-101 in Patients With Carcinoma In Situ (CIS) Bladder Cancer
    Carolina Urologic Research Center
    Myrtle Beach, South Carolina 29572
    Carcinoma in Situ, Non Muscle Invasive Bladder Cancer
    Safety and Tolerability of ODM-201 in Castrate Resistant Prostate Cancer; Extension Study to Study 3104001
    Carolina Urologic Research Center
    Myrtle Beach, South Carolina 29572
    Prostate Cancer
    Study of a 6-Month Sustained-Release Formulation of Leuprolide Acetate in Prostate Cancer
    Grand Strand Urology
    Myrtle Beach, South Carolina 29572
    Prostatic Neoplasms
    Liposomal Doxorubicin and Thermal Therapy in Treating Patients With Prostate Cancer
    Grand Strand Urology LLP
    Myrtle Beach, South Carolina 29572
    Prostate Cancer
    The Effect of Zoledronic Acid on Bone Loss in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy
    Carolina Urologic Research Center
    Myrtle Beach, South Carolina 29572
    Prostate Cancer
    Evaluate the Effects of GPI 1485 on Erectile Function Following Bilateral Nerve-Sparing Prostatectomy
    Carolina Urologic Research Center
    Myrtle Beach, South Carolina 29572
    Impotence, Prostate Cancer
    Study of Abarelix in Androgen-Independent Prostate Cancer Progressing After Agonist Therapy
    Carolina Urologic Research Center
    Myrtle Beach, South Carolina 29572
    Prostate Cancer
    The Plenaxis® Experience Study
    Carolina Urologic Research Center
    Myrtle Beach, South Carolina 29572
    Prostate Cancer
    Leuprolide Acetate 3.75 mg Depot to Treat Prostate Cancer
    Carolina Urologic Research Center
    Myrtle Beach, South Carolina 29572
    Prostate Cancer
    Toremifene Citrate for Prevention of Bone Fractures in Men With Prostate Cancer on Androgen Deprivation Therapy
    Carolina Urologic Research Center
    Myrtle Beach, South Carolina 29572
    Prostate Cancer, Osteoporosis, Fractures
    The Efficacy and Safety of Degarelix One Month Dosing Regimens in Prostate Cancer
    Grand Strand Urology
    Myrtle Beach, South Carolina 29572
    Prostate Cancer
    TroVax Renal Immunotherapy Survival Trial
    Carolina Urologic Research Center
    Myrtle Beach, South Carolina 29572
    Clear Cell Renal Carcinoma
    Assessment and Tracking of Long-term Alefacept Safety
    Grand Strand Dermatology, LLC
    Myrtle Beach, South Carolina 29588
    Psoriasis
    Study of Vicinium for Treating Patients With Non-Invasive Urothelial Carcinoma In Situ
    Grand Strand Urology
    Myrtle Beach, South Carolina 29572
    Urinary Bladder Cancer, Bladder Cancer, Bladder Neoplasms, Bladder Tumors
    Study Using a Genomic Predictor of Platinum Resistance to Guide Therapy in Stage IIIB/IV Non-Small Cell Lung Cancer
    Coastal Cancer Center
    Myrtle Beach, South Carolina 29572
    Non Small Cell Lung Cancer
    Adjuvant Cisplatin With Either Genomic-Guided Vinorelbine or Pemetrexed for Early Stage Non-Small-Cell Lung Cancer
    Coastal Cancer Center
    Myrtle Beach, South Carolina 29572
    Carcinoma, Non-Small-Cell Lung
    A Study of Leuprolide to Treat Prostate Cancer
    Site Reference ID/Investigator# 8689
    Myrtle Beach, South Carolina 29572
    Prostate Cancer
    Efficacy and Safety Study of a New Leuprolide Acetate 17 mg Depot to Treat Prostate Cancer Patients
    Carolina Urologic Research Center
    Myrtle Beach, South Carolina 29572
    Prostate Cancer
    Study of Telintra for Treatment of Chemotherapy Induced Neutropenia in Patients With Non‑Small Cell Lung Cancer
    Coastal Cancer Center
    Myrtle Beach, South Carolina 29572
    Non-small Cell Lung Cancer
    Immunotherapy For Men With Objective Disease Progression On Protocol D9902 Part B (NCT00065442)
    Grand Strand Urology
    Myrtle Beach, South Carolina 29572
    Metastatic Androgen Independent Prostate Cancer
    Observational Study of Subjects Having Routine Recurrence Screening for Bladder Cancer
    Carolina Urologic Research Center
    Myrtle Beach, South Carolina 29572
    Bladder Cancer Recurrence
    A Study of Degarelix in Patients With Prostate Cancer
    Carolina Urologic Research Center
    Myrtle Beach, South Carolina 29572
    Prostate Cancer
    A Trial of Degarelix in Patients With Prostate Cancer
    Grand Strand Urology
    Myrtle Beach, South Carolina 29572
    Prostate Cancer
    Hematuria Evaluation Trial for Subjects With Microscopic or Gross Hematuria to Determine the Absence or Presence of Bladder Cancer
    Carolina Urologic Research Center
    Myrtle Beach, South Carolina 29572
    Microscopic or Gross Hematuria
    Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer
    Carolina Urologic Research Center
    Myrtle Beach, South Carolina 29572
    Bladder Neoplasm, Intravesical Drug Administration, Neoplasm Recurrence, Local, Transitional Cell, Carcinoma, Carcinoma in Situ, Mycobacterium
    A Degarelix Trial in Patients With Prostate Cancer
    Carolina Urologic Research Center
    Myrtle Beach, South Carolina 29572
    Prostate Cancer
    Effect of GTx-758 on Total and Free Testosterone Levels in Men With Prostate Cancer
    GTx Investigative Site
    Myrtle Beach, South Carolina 29572
    Prostate Cancer
    Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer
    Carolina Urologic Research Center
    Myrtle Beach, South Carolina 29572
    Prostate Cancer